Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Medical devices / Patient monitoring and vital-sign devices

SubmarketREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Patient monitoring and vital-sign devices

Devices that continuously or intermittently measure physiological parameters at the bedside or in ambulatory settings, including cardiac monitors, pulse oximeters, blood-pressure devices, incubators and connected monitoring hardware.

Market size
$87.3B
$87.3B ($81.2B–$89.6B) · 2026 · Bottom-up
Growth
+6.3%
$152B by 2035
Attractiveness
— /100
for B2B sellers
Evidence
Low confidence
2 sources · Bottom-up
Level
Submarket
Segmented by
Use case
Buyers
Hospitals, ambulatory and alternative-care sites, physician practices
Buying centre
Clinical engineering, nursing leadership, biomedical engineering, procurement, value analysis, finance
Maturity
Growth
Structure
Fragmented
Buying triggers
  • Hospital monitoring-equipment replacement budgets
  • Expansion of ambulatory and home-care programs [6]
  • New connected-device launches
  • Cybersecurity and interoperability procurement standards
Pains
  • False alarms and weak signal quality reduce clinical confidence
  • Integration with clinical systems is costly and can delay deployment
  • Calibration, reliability and consumable availability affect total cost of ownership
  • Buyers need proof that monitoring reduces workload and improves care outcomes
Scores (1–5)
Pain intensity—
Purchasing power—
Reachability—
Growth—
Growth drivers
  • Hospitals, clinics, ambulatory facilities and home-care programs buy cardiac monitors, pulse oximeters, blood-pressure devices, incubators and connected monitoring hardware.
  • Aging populations and chronic disease increase monitoring needs [6][7].
  • The shift toward home and outpatient care creates demand for portable and connected devices [6].
  • Installed-base replacement and connected-hardware upgrades support recurring sales.
Headwinds
  • Reimbursement constraints can restrict connected-monitoring adoption [7].
  • Interoperability requirements increase development and integration costs.
  • Tighter device regulation raises documentation and approval burdens [7].
  • Hospitals use competitive tenders and emphasize total cost of ownership.
Trends
  • Monitoring is moving from bedside-only use toward ambulatory and home settings [6].
  • Connected hardware is becoming part of broader clinical and enterprise systems.
  • Vendors increasingly combine devices with reusable sensors and other attached consumables.
  • Purchasing is split between acute-care replacement cycles and distributed home-care deployments.

Niches 3

Split by customer type.

Niche75/100

Acute-care inpatient monitoring

Hospitals buying cardiac monitors, multiparameter patient monitors, pulse oximeters, blood-pressure monitors, incubators and connected monitoring hardware for standard wards, inten

—
Hospitals (acute-care and critical-care departments)
not sizedOpen
Niche70/100

Ambulatory and alternative-care monitoring

Ambulatory surgery centres, urgent-care clinics, physician practices, dialysis centres and other alternative-care sites buying compact vital-sign monitors, pulse oximeters, blood-p

—
Ambulatory and alternative-care sites, including physician practices
not sizedOpen
Niche75/100

Connected and remote patient monitoring

Hospitals, ambulatory sites and physician practices buying connected monitoring hardware and software-enabled vital-sign devices that transmit data to clinical teams for remote sur

—
Hospitals, ambulatory and alternative-care sites, and physician practices
not sizedOpen

Companies in this market 6

Named in public sources; linked to the source.

How this was sized

$87.3B ($81.2B–$89.6B) · 2026 · Bottom-up

No source provides a matching share for this submarket. Bottom-up share assumption: 14% of the scoped sector. Arithmetic: $623.37bn x 14% = $87.272bn in 2026. Low and high estimates apply 14% to the sector range from [4]. Constant-share forecast: $87.272bn x 1.0634^9 = $151.755bn in 2035.

Alongside it in Medical devices

// Sell into Patient monitoring and vital-sign devices

AOS finds the biggest accounts in this submarket with a reason to talk now, maps their buying centre and prepares the outreach for your approval.